Radiopharmaceuticals

• 
  PET radiopharmaceutical for Parkinson’s Disease

  - Signed with Columbia University for research for clinical research trial

  - Phase 1 trial in the works

• 
  PET radiopharmaceutical for Alzheimer’s Disease

  - Signed a license agreement with Moltek in Turkey

  - Preparation of product registration in process in Turkey

• 
  PET radiopharmaceutical for prostate cancer

  - Obtained US FDA IND approval for Phase 1 trial at the Johns Hopkins Hospital

  - Signed a license agreement with IASON GmbH in Europe

• FC705
  (Therapeutic)
  Therapeutic radiopharmaceutical for prostate cancer

  - Completed non-clinical trials

  - Signed a CRO agreement with Linical Korea

  - Phase 1 trial in progress